Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.

Raess MA, Cowling BS, Bertazzi DL, Kretz C, Rinaldi B, Xuereb JM, Kessler P, Romero NB, Payrastre B, Friant S, Laporte J.

Hum Mol Genet. 2017 Oct 1;26(19):3736-3748. doi: 10.1093/hmg/ddx258.

PMID:
28934386
2.

Expression of myotubularins in blood platelets: Characterization and potential diagnostic of X-linked myotubular myopathy.

Mansour R, Severin S, Xuereb JM, Gratacap MP, Laporte J, Buj-Bello A, Tronchère H, Payrastre B.

Biochem Biophys Res Commun. 2016 Jul 29;476(3):167-73. doi: 10.1016/j.bbrc.2016.04.127. Epub 2016 May 4.

PMID:
27155155
3.

The bvFTD phenocopy syndrome: a clinicopathological report.

Devenney E, Forrest SL, Xuereb J, Kril JJ, Hodges JR.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1155-6. doi: 10.1136/jnnp-2015-312826. Epub 2016 Apr 15. No abstract available.

PMID:
27083530
4.

PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment.

Boal F, Puhar A, Xuereb JM, Kunduzova O, Sansonetti PJ, Payrastre B, Tronchère H.

Cell Rep. 2016 Feb 2;14(4):750-759. doi: 10.1016/j.celrep.2015.12.079. Epub 2016 Jan 14.

5.

Phosphoinositides: Important lipids in the coordination of cell dynamics.

Viaud J, Mansour R, Antkowiak A, Mujalli A, Valet C, Chicanne G, Xuereb JM, Terrisse AD, Séverin S, Gratacap MP, Gaits-Iacovoni F, Payrastre B.

Biochimie. 2016 Jun;125:250-8. doi: 10.1016/j.biochi.2015.09.005. Epub 2015 Sep 25. Review.

PMID:
26391221
6.

TOM1 is a PI5P effector involved in the regulation of endosomal maturation.

Boal F, Mansour R, Gayral M, Saland E, Chicanne G, Xuereb JM, Marcellin M, Burlet-Schiltz O, Sansonetti PJ, Payrastre B, Tronchère H.

J Cell Sci. 2015 Feb 15;128(4):815-27. doi: 10.1242/jcs.166314. Epub 2015 Jan 14.

7.

Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1.

Viaud J, Lagarrigue F, Ramel D, Allart S, Chicanne G, Ceccato L, Courilleau D, Xuereb JM, Pertz O, Payrastre B, Gaits-Iacovoni F.

Nat Commun. 2014 Jun 6;5:4080. doi: 10.1038/ncomms5080.

PMID:
24905281
8.

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration.

Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):925-9. doi: 10.1136/jnnp-2013-307035. Epub 2014 Feb 12.

9.

White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?

Charidimou A, Jaunmuktane Z, Baron JC, Burnell M, Varlet P, Peeters A, Xuereb J, Jäger R, Brandner S, Werring DJ.

Neurology. 2014 Jan 7;82(1):57-62. doi: 10.1212/01.wnl.0000438225.02729.04. Epub 2013 Nov 27.

10.

Neuropathology training worldwide-evolution and comparisons.

Del Bigio MR, Hainfellner JA, McLean CA, Powell SZ, Sikorska B, Takahashi H, Weis J, Xuereb JH.

Brain Pathol. 2014 Apr;24(3):285-98. doi: 10.1111/bpa.12104.

PMID:
24251639
11.

Pathogenic mitochondrial tRNA point mutations: nine novel mutations affirm their importance as a cause of mitochondrial disease.

Blakely EL, Yarham JW, Alston CL, Craig K, Poulton J, Brierley C, Park SM, Dean A, Xuereb JH, Anderson KN, Compston A, Allen C, Sharif S, Enevoldson P, Wilson M, Hammans SR, Turnbull DM, McFarland R, Taylor RW.

Hum Mutat. 2013 Sep;34(9):1260-8. doi: 10.1002/humu.22358.

12.

Neuropathological correlates of falling in the CC75C population-based sample of the older old.

Richardson K, Hunter S, Dening T, Xuereb JH, Matthews FE, Brayne C, Fleming J; Cambridge City over-75s Cohort (CC75C) Study Neuropathology Collaboration.

Curr Alzheimer Res. 2012 Jul;9(6):697-708.

PMID:
22471864
13.

The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.

Lhermusier T, van Rottem J, Garcia C, Xuereb JM, Ragab A, Martin V, Gratacap MP, Sié P, Payrastre B.

J Thromb Haemost. 2011 Oct;9(10):2067-76. doi: 10.1111/j.1538-7836.2011.04470.x.

14.

The relationship between clinical and pathological variables in Richardson's syndrome.

Schofield EC, Hodges JR, Bak TH, Xuereb JH, Halliday GM.

J Neurol. 2012 Mar;259(3):482-90. doi: 10.1007/s00415-011-6205-8. Epub 2011 Aug 12.

PMID:
21837549
15.

Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia.

Corti C, Xuereb JH, Crepaldi L, Corsi M, Michielin F, Ferraguti F.

Schizophr Res. 2011 May;128(1-3):7-14. doi: 10.1016/j.schres.2011.01.021. Epub 2011 Feb 24.

PMID:
21353485
16.

Clinical phenotypes in autopsy-confirmed Pick disease.

Piguet O, Halliday GM, Reid WG, Casey B, Carman R, Huang Y, Xuereb JH, Hodges JR, Kril JJ.

Neurology. 2011 Jan 18;76(3):253-9. doi: 10.1212/WNL.0b013e318207b1ce.

PMID:
21242493
17.

Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow.

Terrisse AD, Puech N, Allart S, Gourdy P, Xuereb JM, Payrastre B, Sié P.

J Thromb Haemost. 2010 Dec;8(12):2810-9. doi: 10.1111/j.1538-7836.2010.04088.x.

18.

Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology.

Xiong L, Xuereb JH, Spillantini MG, Patterson K, Hodges JR, Nestor PJ.

J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):254-60. doi: 10.1136/jnnp.2010.209916. Epub 2010 Sep 14.

PMID:
20841368
19.

Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.

Mukaetova-Ladinska EB, Xuereb JH, Garcia-Sierra F, Hurt J, Gertz HJ, Hills R, Brayne C, Huppert FA, Paykel ES, McGee MA, Jakes R, Honer WG, Harrington CR, Wischik CM.

ScientificWorldJournal. 2009 Dec 16;9:1463-75. doi: 10.1100/tsw.2009.151.

20.

Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases.

Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, Nestor PJ, Patterson K.

Brain. 2010 Jan;133(Pt 1):300-6. doi: 10.1093/brain/awp248. Epub 2009 Oct 5.

PMID:
19805492
21.

Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains.

van Eersel J, Bi M, Ke YD, Hodges JR, Xuereb JH, Gregory GC, Halliday GM, Götz J, Kril JJ, Ittner LM.

J Neural Transm (Vienna). 2009 Oct;116(10):1243-51. doi: 10.1007/s00702-009-0293-y. Epub 2009 Aug 20.

PMID:
19693433
22.

Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study.

Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, Paykel E, Mukaetova-Ladinska EB, Huppert FA, O'Sullivan A, Dening T; Cambridge City Over-75s Cohort Cc75c Study Neuropathology Collaboration.

J Alzheimers Dis. 2009;18(3):645-58. doi: 10.3233/JAD-2009-1182.

PMID:
19661624
23.

Is the pathology of corticobasal syndrome predictable in life?

Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH.

Mov Disord. 2009 Aug 15;24(11):1593-9. doi: 10.1002/mds.22558.

PMID:
19533751
24.

Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.

Pereira JM, Williams GB, Acosta-Cabronero J, Pengas G, Spillantini MG, Xuereb JH, Hodges JR, Nestor PJ.

Neurology. 2009 May 12;72(19):1653-60. doi: 10.1212/WNL.0b013e3181a55fa2.

25.

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.

Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, Greally E, Robson J, Jaros E, Perry R, McKeith IG, Brayne C, Xuereb J, Cleghorn A, Doherty J, McIntosh G, Milton I.

Dement Geriatr Cogn Disord. 2008;26(1):32-42. doi: 10.1159/000141039. Epub 2008 Jun 25.

PMID:
18577885
26.

The neural basis of semantic memory: evidence from semantic dementia.

Davies RR, Halliday GM, Xuereb JH, Kril JJ, Hodges JR.

Neurobiol Aging. 2009 Dec;30(12):2043-52. doi: 10.1016/j.neurobiolaging.2008.02.005. Epub 2008 Mar 25.

PMID:
18367294
27.

High grade glioma: imaging combined with pathological grade defines management and predicts prognosis.

Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, Xuereb JH, Pohl U.

Radiother Oncol. 2007 Dec;85(3):371-8. Epub 2007 Nov 26.

PMID:
18035440
28.

Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals.

Downes EC, Robson J, Grailly E, Abdel-All Z, Xuereb J, Brayne C, Holland A, Honer WG, Mukaetova-Ladinska EB.

Neuropathol Appl Neurobiol. 2008 Feb;34(1):12-22. Epub 2007 Nov 15.

PMID:
18005332
29.
30.

Focal cortical presentations of Alzheimer's disease.

Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR.

Brain. 2007 Oct;130(Pt 10):2636-45.

PMID:
17898010
31.

Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia.

Corti C, Crepaldi L, Mion S, Roth AL, Xuereb JH, Ferraguti F.

Biol Psychiatry. 2007 Oct 1;62(7):747-55. Epub 2007 May 24.

PMID:
17531207
32.

Sporadic malignant nerve sheath tumour of the oculomotor nerve.

Santarius T, Chia HL, Xuereb JH, Kirollos RW.

Acta Neurochir (Wien). 2007 Jun;149(6):617-22; discussion 622. Epub 2007 May 21.

PMID:
17514351
33.

Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia.

Nestor PJ, Balan K, Cheow HK, Fryer TD, Knibb JA, Xuereb JH, Hodges JR.

Neurology. 2007 Jan 16;68(3):238-9. No abstract available.

PMID:
17224582
34.

Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology.

Kersaitis C, Halliday GM, Xuereb JH, Pamphlett R, Bak TH, Hodges JR, Kril JJ.

Neuropathol Appl Neurobiol. 2006 Feb;32(1):83-91.

PMID:
16409556
35.

Clinical and pathological characterization of progressive aphasia.

Knibb JA, Xuereb JH, Patterson K, Hodges JR.

Ann Neurol. 2006 Jan;59(1):156-65.

PMID:
16374817
36.

Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing.

Bak TH, Yancopoulou D, Nestor PJ, Xuereb JH, Spillantini MG, Pulvermüller F, Hodges JR.

Brain. 2006 Feb;129(Pt 2):321-32. Epub 2005 Dec 5.

PMID:
16330501
37.

The pathological basis of semantic dementia.

Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH.

Brain. 2005 Sep;128(Pt 9):1984-95. Epub 2005 Jul 6.

PMID:
16000337
38.

Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia.

Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG.

J Neuropathol Exp Neurol. 2005 Mar;64(3):245-53.

PMID:
15804056
39.

Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study.

Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, Xuereb J, Cairns NJ, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Williams J, Rubinsztein DC.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):5-8.

PMID:
15690550
40.

Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy.

Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S.

Brain. 2005 Mar;128(Pt 3):500-15. Epub 2005 Jan 19.

PMID:
15659428
41.

Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease.

Jamieson SE, White JK, Howson JM, Pask R, Smith AN, Brayne C, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC, Blackwell JM.

Neurosci Lett. 2005 Feb 10;374(2):124-8.

PMID:
15644277
42.

Pathologically proven frontotemporal dementia presenting with severe amnesia.

Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J.

Brain. 2005 Mar;128(Pt 3):597-605. Epub 2005 Jan 5.

PMID:
15634737
43.

The human perirhinal cortex and semantic memory.

Davies RR, Graham KS, Xuereb JH, Williams GB, Hodges JR.

Eur J Neurosci. 2004 Nov;20(9):2441-6.

PMID:
15525284
44.

Clinicopathological correlates in frontotemporal dementia.

Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM.

Ann Neurol. 2004 Sep;56(3):399-406.

PMID:
15349867
45.

Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study.

Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Fryer T, Guadagno JV, Warburton EA.

Stroke. 2004 Jul;35(7):1659-64. Epub 2004 May 20.

PMID:
15155970
46.

Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease.

Cook LJ, Ho LW, Taylor AE, Brayne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D, St Clair D, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Owen MJ, Williams J, Lendon C, Rubinsztein DC.

Neurosci Lett. 2004 Mar 25;358(2):142-6.

PMID:
15026168
47.

Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy.

Harkness KA, Coles A, Pohl U, Xuereb JH, Baron JC, Lennox GG.

Eur J Neurol. 2004 Jan;11(1):59-62.

PMID:
14692890
48.

Survival in frontotemporal dementia.

Hodges JR, Davies R, Xuereb J, Kril J, Halliday G.

Neurology. 2003 Aug 12;61(3):349-54.

PMID:
12913196
49.

Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells.

Corti C, Clarkson RW, Crepaldi L, Sala CF, Xuereb JH, Ferraguti F.

J Biol Chem. 2003 Aug 29;278(35):33105-19. Epub 2003 Jun 3.

50.

No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease.

Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC.

Ann Neurol. 2002 Nov;52(5):690-1. No abstract available.

PMID:
12402275

Supplemental Content

Loading ...
Support Center